Radiology, Mayo Clinic, Rochester, Minnesota, USA
Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.
Stroke Vasc Neurol. 2021 Dec;6(4):658-667. doi: 10.1136/svn-2021-001032. Epub 2021 Jul 26.
There has been growing interest and insight into the histological composition of retrieved stroke emboli. One of the main focuses of the stroke clot analysis literature has been the implications of clot composition on mechanical thrombectomy procedures. However, the holy grail of clot analysis may not be in the field of clot-device interaction, but rather, in understanding mechanisms of fibrinolysis resistance. The mechanisms underlying the low response to fibrinolytic therapy, even with the newer, more powerful agents, remain poorly understood. While factors such as embolus size, location and collateral status influence alteplase delivery and recanalisation rates; compositional analyses focused on histological and ultrastructural characteristics offer unique insights into mechanisms of alteplase resistance. In this review, we strive to provide comprehensive review of current knowledge on clot composition and ultrastructural analyses that help explain resistance to fibrinolysis.
人们对回收的中风栓子的组织学成分越来越感兴趣,并加深了了解。中风血栓分析文献的主要焦点之一是血栓成分对机械血栓切除术程序的影响。然而,血栓分析的圣杯可能不在于血栓-器械相互作用领域,而在于理解纤维蛋白溶解抵抗的机制。即使使用更新、更有效的药物,纤维蛋白溶解治疗反应率低的机制仍未得到很好的理解。虽然栓子大小、位置和侧支循环状态等因素会影响阿替普酶的输送和再通率;但针对组织学和超微结构特征的成分分析为阿替普酶抵抗的机制提供了独特的见解。在这篇综述中,我们努力提供关于血栓成分和超微结构分析的最新知识的全面综述,这些知识有助于解释纤维蛋白溶解抵抗的机制。